Let's celebrate the first Wednesday in September with #SIDPWelcomeWednesdays! Say hello to 5⃣ of our newest members! 👋 Thanks for being a part of SIDP! 🎉🤓🦠💊

Just found out they give live fish CT scans by placing them on a wet sponge and I can’t stop thinking about it

🆕️⚡️🔥 State of art article #CID State of the Management of Infections Caused by MDR organisms SIDP 🌟s arsheena yassin @jpogue1 🔆Case vignette 🔆Risk factors for MDR-GN infection 🔆Choice of empiric Rx& Diagonstics 🔆Definitive Rx 🔆Duration #IDXposts academic.oup.com/cid/article/do…

Reminder: We are studying COVID rebound, including Paxlovid rebound. If you tested positive within the past 2 days, please take a look below A Fully at-home study that sends everything to your house and compensates $ for your time/energy/participation

More reassuring data! 🆕️⚡️⚡️Multi-institutional analysis Short (med 8d ) was non-inferior in terms of clinical outcomes to prolonged (med 15d) -course antibiotics for treatment of pseudomonas aeruginosa BSI in hem-onc pts with FN Brad Spellberg #IDXposts academic.oup.com/cid/advance-ar…

🔥🔥 IDSA cUTI Clinical Guideline Updates: -UTI definitions updated -Duration of therapy for cUTI = 7 days for most patients #IDWeek2023 #IDTwitter #TwitteRx #SIDP2023

🔔 Please share, Baptist Health Academics is recruiting for a PGY2 infectious diseases pharmacy resident. 🤩 9 BCIDP preceptors. 9 preceptors with PGY2 training in ID. Attendance at IDweek, MAD-ID, ASHP MCM, and ECCMID. Exposure to a system with 12 hospitals, >100 outpatient centers, home

It has been proposed that doxycycline may be protective against CDI 🆕️✨️✨️Large VAH retrospective analysis 17% decreased risk of CDI was identified with doxycycline compared to azithromycin when used with ceftriaxone for treatment of CAP (P = .03) sciencedirect.com/science/articl…

Non-stop infectious diseases learning process Stay up-to-date in Infectious Diseases Follow Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 Shamless self-promotion #IDXposts AKA #IDTwitter #MedEd

Linezolid had similar rates of clinical cure to vancomycin in a pooled meta-analysis of bacteremic patients from 5 RCTs of infections due to S. aureus (not limited to SAB),although the number of patients with MRSA bacteremia was low (52 of 3228 enrolled patients) #IDXposts #MedEd

Jeff Pearson Zain Chagla JAC-AMR Skyler Starkel Melanie Goodberlet Brian Schuler Alex Rock, PharmD, AAHIVP, BCPS, BCIDP 🏳️‍🌈 Yes it is beyond time to ditch gent because in 2024 we never would have accepted it based on the supporting data. Weak evidence benefit. Proven harms. Primum non nocere. Emily McDonald Brad Spellberg jamanetwork.com/journals/jaman…

🔥Just published🔥 Open Forum Infectious Diseases By many super 🌟s SIDP Reagan Kiger Barfield Chris Bland P. Brandon Bookstaver Bug Pharmacist 💊🧫 Tim Gauthier et Al Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022 #idxposts H/t ACCP INFD PRN academic.oup.com/ofid/advance-a…

Anil Makam No just POET. Heldman et al. was 100% S. aureus and 100% oral (no IV lead in). And of course there was also the French quasi-experimental study, which was 100% S. aureus. Summary Table, and forrest plot with and without the quasi experimental study. bradspellberg.com/oral-antibioti…

Perfect example of how far from benign antibiotics (especially FQs!) are

Post-residency plans hard launch - Incredibly thankful to be staying at Erlanger after my PGY2!

ASB? Let it be 🙅‍♀️ #SIDP #stewardship #TwitteRx #IDtwitter

🚨JOB ALERT 🚨 Pharmacy Residency Program at Erlanger is hiring a MICU/NNICU pharmacist! ▪️Level 1 Trauma, Academic Medical Center ▪️Academic & APP rounding teams ▪️PGY1 and PGY2-CC pharmacy residencies ▪️Pulmonary Care Fellowship starting in 2025 Apply here ⬇️ erlanger.taleo.net/careersection/…

~90% of pharmacy residency projects do not go onto publication This indicates that we have a process that is not teaching high quality scientific / scholarship methods OR a process that is not in alignment with the true goal (e.g., an understanding of the quality improvement

1/2 Dr. Shruti Gohil UCI Health presented INSPIRE data on intra-abdominal infections (IAIs) at #IDWeek2024. IAIs involve diverse organs/spaces. Yet, only 1% (+) for MRSA and another 1% (+) for Pseudomonas, despite 63% of patients getting empiric broad-spectrum abx treatment.